Multiple Assemblies exist for SMTL entry 5xj3
Complex structure of ipilimumab-scFv and CTLA-4; X-RAY DIFFRACTION 3.20 Å

	SMTL ID 5xj3.1 Ligands - Polypeptides ipilimumab-VH Oligo-state monomer
	SMTL ID 5xj3.2 Ligands - Polypeptides ipilimumab-VL Oligo-state monomer
	SMTL ID 5xj3.3 Ligands - Polypeptides Cytotoxic T-lymphocyte protein 4 Oligo-state monomer
	SMTL ID 5xj3.4 Ligands - Polypeptides ipilimumab-VH Oligo-state monomer
	SMTL ID 5xj3.5 Ligands - Polypeptides ipilimumab-VL Oligo-state monomer
	SMTL ID 5xj3.6 Ligands - Polypeptides Cytotoxic T-lymphocyte protein 4 Oligo-state monomer
	SMTL ID 5xj3.7 Ligands - Polypeptides ipilimumab-VH Oligo-state monomer
	SMTL ID 5xj3.8 Ligands - Polypeptides ipilimumab-VL Oligo-state monomer
	SMTL ID 5xj3.9 Ligands - Polypeptides Cytotoxic T-lymphocyte protein 4 Oligo-state monomer
	SMTL ID 5xj3.10 Ligands - Polypeptides ipilimumab-VH Oligo-state monomer
	SMTL ID 5xj3.11 Ligands - Polypeptides ipilimumab-VL Oligo-state monomer
	SMTL ID 5xj3.12 Ligands - Polypeptides Cytotoxic T-lymphocyte protein 4 Oligo-state monomer